Preeti Joshi
Overview
Explore the profile of Preeti Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi P, Boyce J, Larson E, Landon E, Bearman G, Stewart K, et al.
Am J Infect Control
. 2025 Mar;
PMID: 40058599
Background: Healthcare-associated infections (HAIs) remain a major concern in U.S. hospitals, contributing to significant patient mortality and medical costs. Studies indicate that up to 70% of HAIs are preventable, with...
2.
Joshi P, Patel R, Singh A, Nenavathu B, Sharma M, Verma S, et al.
Nanotechnology
. 2024 Jul;
35(39).
PMID: 38955171
The current work emphasizes the preparation of trimetallic core-shell Ag-TeO@ZnO nanocomposites (NCs) by thermo-mechanical method for the efficient photocatalytic degradation of 2,4-Dichlorophenol and β-naphthol pollutants. FE-SEM shows that Ag and...
3.
Singh A, Modi S, Joshi P, Nenavathu B, Singh M, Verma S, et al.
Chemosphere
. 2023 Nov;
348:140658.
PMID: 37956931
We have utilised our TeO-ZnO nanocomposites for Yamuna wastewater treatment in natural sunlight wherein the sampling site was Nigam Bodh Ghat, Kashmere Gate, Delhi. In BET isotherm, TZ NCs exhibited...
4.
Singh R, Amoaku W, Bandello F, Chen F, Holz F, Kodjikian L, et al.
Ophthalmic Surg Lasers Imaging Retina
. 2023 Oct;
54(10):589-598.
PMID: 37847167
Geographic atrophy (GA) is a progressive and irreversible retinal disease with no comprehensive recommendations for diagnosis or monitoring. We used a Delphi approach to determine consensus in key areas around...
5.
Deva M, Osborne J, McGlynn A, Soars L, Loghdey S, Beath K, et al.
Int J Integr Care
. 2023 May;
23(2):12.
PMID: 37151779
Introduction: As the most common cancer in Australia, skin cancer generates a considerable health burden. This study outlines the establishment of a new model of integrated care for the diagnosis...
6.
Vale S, Said M, Smith J, Joshi P, Loh R
World Allergy Organ J
. 2022 Oct;
15(11):100706.
PMID: 36267355
Background: Allergic diseases have become an increasing health issue worldwide, being one of the fastest growing chronic diseases in Australia and other westernized countries. In 2013, allergic diseases were reported...
7.
Liao D, Metlapally R, Joshi P
Immunotherapy
. 2022 Jul;
14(13):995-1006.
PMID: 35860926
What Is This Summary About?: This is a summary of a publication about the FILLY study, which was published in in 2020. The FILLY study looked at an investigational medicine...
8.
Yoshida Y, Joshi P, Barri S, Wang J, Corder A, OConnell S, et al.
J Diabetes Complications
. 2022 Jul;
36(8):108255.
PMID: 35817678
Aims: The effect of Glucagon-like peptide 1 receptor agonists (GLP1 RA) on diabetic retinopathy (DR) remains controversial. Previous reviews combined data from randomized clinical trials (RCTs) with or without cardiovascular...
9.
Vale S, Roche I, Netting M, Said M, Joshi P, Clifford R, et al.
Aust N Z J Public Health
. 2022 May;
46(4):438-443.
PMID: 35616393
Objective: To identify a brand, key messages and resources to underpin a public health approach to food allergy prevention. Methods: A focus group design was used to explore perceptions and...
10.
Frith K, Smith J, Joshi P, Ford L, Vale S
Aust Prescr
. 2021 Jul;
44(3):91-95.
PMID: 34211247
Severe allergic reactions (anaphylaxis) are unpredictable, and initial signs of what could be fatal anaphylaxis can be mild Adrenaline (epinephrine) remains the first-line drug of choice for the acute management...